DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2DIVALPROEX SODIUM
02 1GLIPIZIDE
03 1MORPHINE SULFATE
04 1NIFEDIPINE
05 1PENTOXIFYLLINE
01 175028
02 175289
03 176467
04 190070
05 190161
06 1205634
01 6No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90070
Country : US
Patented : No
Drug : GLIPIZIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76467
Country : US
Patented : No
Drug : NIFEDIPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75289
Country : US
Patented : No
Drug : PENTOXIFYLLINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75028
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 205634
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90161
Country : US
Patented : No
